Efficacy of Topical 95% TCA in the Treatment of CIN 1 or Less After Low-grade Abnormality of Screening Test

• Status: Withdrawn
• Trial end date: 2023-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

To evaluate the efficacy of topical 95% TCA in the treatment of CIN 1 or less after low grade abnormality of screening test

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Rajavithi Hospital
• Treatments: Acetic Acid

Criteria

Inclusion Criteria:

• Women who have low-grade abnormality result such as ASC-US, LSIL, HPV 16/18 positive, persistent HPV infection after cervical cancer screening test

• No history of endometrial or cervical cancer

• Pregnancy test negative

• Good communication in Thai language

• Vouluntarily participate to the study

Exclusion Criteria:

• Pregnancy test positive after participate in the study

• Pathologic result from colposcopic biopsy (before intervention) is high-grade abnormality such as HSIL, CIN2-3 or AIS